JP Morgan Chase’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $6.37M | Buy |
|
|||||
|
2023
Q3 | $3.04M | Buy |
|
|||||
|
2023
Q2 | $1.41M | Sell |
|
|||||
|
2023
Q1 | $2.23M | Buy |
|
|||||
|
2022
Q4 | $1.95M | Sell |
|
|||||
|
2022
Q3 | $11.2M | Buy |
|
|||||
|
2022
Q2 | $3.67M | Buy |
|
|||||
|
2022
Q1 | $2.32M | Buy |
|
|||||
|
2021
Q4 | $3.83M | Buy |
|
|||||
|
2021
Q3 | $4.04M | Sell |
|
|||||
|
2021
Q2 | $4.13M | Sell |
|
|||||
|
2021
Q1 | $56.7M | Sell |
|
|||||
|
2020
Q4 | $78.9M | Buy |
|
|||||
|
2020
Q3 | $45.6M | Buy |
|
|||||
|
2020
Q2 | $1.85M | Buy |
|
|||||
|
2020
Q1 | $824K | Sell |
|
|||||
|
2019
Q4 | $2.22M | Buy |
|
|||||
|
2019
Q3 | $801K | Buy |
|
|||||
|
2019
Q2 | $871K | Buy |
|
|||||
|
2019
Q1 | $577K | Buy |
|
|||||
|
2018
Q4 | $219K | Buy |
|
|||||
|
2018
Q3 | $220K | Buy |
|
|||||
|
2018
Q2 | $181K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $32K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $194K | Sell |
|
|||||
|
2016
Q4 | $258K | Buy |
|
|||||
|
2016
Q3 | $199K | Sell |
|
|||||
|
2016
Q2 | $308K | Sell |
|
|||||
|
2016
Q1 | $1.65M | Buy |
|
|||||
|
2015
Q4 | $2.31M | Sell |
|
|||||
|
2015
Q3 | $2.81M | Buy |
|
|||||
|
2015
Q2 | $2.5M | Sell |
|
|||||
|
2015
Q1 | $2.5M | Sell |
|
|||||
|
2014
Q4 | $1.65M | Sell |
|
|||||
|
2014
Q3 | $1.63M | Buy |
|